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Clinical competence statement on thoracic
endovascular aortic repair (TEVAR)—multispecialty
consensus recommendations
A Report of the SVS/SIR/SCAI/SVMB Writing Committee to Develop a
Clinical Competence Standard for TEVARINTRODUCTION
Thoracic endovascular aortic repair (TEVAR) is a min-
imally invasive alternative to open surgical reconstruction
that is being incorporated into vascular surgery, cardiotho-
racic surgery, interventional radiology, interventional car-
diology, and vascular medicine practices. Contemporary
techniques for TEVAR were developed by multiple special-
ists, primarily vascular surgeons, interventional radiolo-
gists, and cardiothoracic surgeons, who often worked
together to combine their complementary skills.1-9 Trans-
ferring technology, operative and interventional skills, and
adjunctive medical therapies developed in their abdominal
aortic aneurysm and peripheral vascular experience, these
specialists demonstrated the feasibility and subsequent effi-
cacy of TEVAR.10 This report delineates the skill set and
knowledge base necessary to successfully perform TEVAR
according to a consensus of opinions of experts who have been
pioneers in developing the technology, have had national
leadership roles in clinical trials, and have trained physicians
who have developed new centers of excellence in TEVAR.
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858TEVAR: THE PROTOTYPICAL
HYBRID PROCEDURE
TEVAR, as its name states, is first and foremost an
endovascular procedure, but it is one that cannot be per-
formed without adjunctive surgical participation. The rela-
tively large size of the thoracic aorta and the physical limits
of compression of thoracic endografts will for the foresee-
able future render TEVAR a procedure that requires surgi-
cal access to the vascular system. Even if advances in percu-
taneous closure devices for large femoral arterial punctures
make access site closure feasible, the marginal diameter of
many external iliac arteries renders this a moot point,
because the surgical creation of an iliac conduit will be
required. Although iliac conduits have been uncommonly
required to provide vascular access for abdominal aortic
endografting (EVAR), up to one quarter of patients may
require them for TEVAR, primarily as a result of the
requisite diameter of the delivery systems, which are typi-
cally in the 24F to 28F range. Given the more frequent
need for both iliac conduits and access vessel repair, secur-
ing vascular access for TEVAR is clearly more complicated
than for EVAR. Additionally, to extend the applicability of
TEVAR, the endograft is commonly placed over the orifice
of the left subclavian artery, and many patients require
extraanatomic surgical revascularization or subclavian-
carotid transposition. Consequently, unless or until tech-
nological advances render these ancillary surgical proce-
dures unnecessary, the need for a surgeon with training and
expertise in these less common exposures and revascular-
ization procedures is readily apparent.
On the interventional side, TEVAR requires the full
endovascular skill set needed to catheterize and treat any of
the vessels in the endograft delivery pathway, including
those the endograft delivery system must be advanced
through or past, as well as those the deployed endograft
may encroach upon: primarily the brachiocephalic and mes-
enteric vessels. TEVAR requires far more in the way of
endovascular skills than simple passage of a guidewire into
the aorta, and expertise with the full range of endoluminal
instrumentation (including large-bore sheaths, guiding
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snares, embolization coils, and, of course, endografts) is
required to ensure a safe and successful procedure. Selective
catheterization skills are needed to optimize precise graft
deployment, and endoluminal intervention skills are needed
to restore perfusion to inadvertently covered or embolized
vessels. Expertise with fluoroscopic guidance, radiographic
technique, acquisition projections, and image postprocess-
ing will ensure optimal endograft placement and recogni-
tion of relevant complicating factors. These interventional
skills are standard elements of the training curricula of the
interventional specialties involved in TEVAR: vascular sur-
gery, interventional radiology, interventional cardiology,
and interventional vascular medicine.
The aforementioned surgical and endoluminal skills aside,
successful TEVAR has a knowledge base requirement—not
just of the nature of thoracic aortic pathology, but also of the
complications attendant to its treatment, such as spinal cord
ischemia, mesenteric ischemia, stroke, and renal insufficiency.
Although this knowledge base is incorporated into vascular
surgery and cardiothoracic fellowship training, it is not a
standard component of training in the other interventional
fields. Nonetheless, unlike surgical skills, the possession of
which relates to one’s medical heritage, the knowledge base
necessary for competence in the management of TEVAR
cases and their complications is something that can be
acquired by any of the involved specialties through con-
tinuing medical education (CME) activities. Another
knowledge requirement for TEVAR is that of computed
tomographic (CT) and angiographic interpretation of tho-
racic vascular pathology to properly diagnose the condi-
tion, determine its suitability for endoluminal repair, per-
form proper TEVAR measurements and planning, and
interpret post-TEVAR imaging studies to determine the
ongoing success of the procedure. These skills are less
specialty specific because they relate more to one’s previous
experience with EVAR or TEVAR than to one’s medical
heritage. As EVAR has become a standard component of all
the interventional specialty training programs, and TEVAR
will likely also, new graduates may be expected to gain this
experience in their fellowships. To ensure uniformity in the
interim, all those seeking TEVAR credentials will have to
document their previous EVAR or TEVAR experience.
ASSEMBLING THE SKILL SET
As detailed previously, safe and successful performance
of TEVAR requires diverse knowledge and technical skills
not usually vested in one physician at the present time. This
explains why most procedures are performed collabora-
tively between surgeons and interventionists. The former
provides the surgical expertise, typically needed for manag-
ing vascular access and performing adjunctive revasculariza-
tions, while the interventionist performs the endoluminal
instrumentation. Because thoracic aortic disease has histor-
ically been a surgical condition, the surgeon on the team,
usually being the most knowledgeable about common peri-
operative problems and their management, has typically
provided the perioperative care. However, other involvedspecialists may acquire the necessary knowledge to assume
this role, just as surgeons may acquire the comprehensive
endovascular skills necessary to safely and independently
perform the endoluminal instrumentation.
Although many contemporary vascular surgeons and a
few cardiothoracic surgeons have acquired comprehensive
peripheral endovascular interventional skills and can per-
form TEVAR independently, most cardiothoracic sur-
geons, who often have large referral bases for thoracic aortic
disease, will need to team up with an interventional special-
ist to safely perform TEVAR. The tendency to minimize
the complexity of the endoluminal instrumentation or pre-
sume that TEVAR experience alone qualifies as compre-
hensive endovascular training and entitles independent
performance of TEVAR cannot be allowed to prevail over
consensus standards of care designed to ensure patient safety
and optimal outcomes. Therefore, although privileges to
independently perform the endoluminal components of
TEVAR can be obtained by vascular or cardiothoracic sur-
geons, who could then perform TEVAR independently, ac-
cepted multispecialty consensus criteria for peripheral endo-
vascular interventional privileges should be followed to
ensure that they are qualified to perform all needed endo-
vascular maneuvers and address all likely complications.
There are presently two multispecialty endovascular cre-
dentialing documents in common use: the recently pub-
lished American College of Cardiology/American College
of Physicians/Society for Cardiovascular Angiography and
Interventions/Society for Vascular Medicine and Biology/
Society for Vascular Surgery (ACC/ACP/SCAI/SVMB/
SVS) clinical competence statement on vascular medicine
and catheter-based peripheral vascular interventions11 and
the American Heart Association training standards for phy-
sicians performing peripheral angioplasty and other percu-
taneous peripheral vascular interventions.12 These docu-
ments are similar in the numbers of procedures required for
credentialing for general endovascular diagnostic and inter-
ventional procedures, and either of these would be consid-
ered currently accepted credentialing standards for unre-
stricted general endovascular competency.
PRINCIPAL REQUIREMENTS FOR
INDIVIDUAL PHYSICIANS OR TEAMS
OF PHYSICIANS
The purpose of this document is to provide standards
regarding physician training and credentialing for TEVAR
to facilitate the safe and orderly dissemination of this new
therapy into clinical practice. This consensus document
should be considered to represent minimum requirements
for training and preparation to perform TEVAR. Although
industry training program requirements may add to these,
they will not lessen or substitute for any component.
Given the diversity of knowledge and skills required, as
well as the multitude of specialties participating, these
requirements have been crafted to allow all interested
disciplines to participate in TEVAR, although this will
often require collaboration with physicians with comple-
mentary skills.
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possess the highest level of certification (or eligibility)
available in their specialty:
1. American Board of Radiology Certificate of Added Qual-
ifications in Vascular and Interventional Radiology.
2. Board Certification in Vascular Surgery by the American
Board of Surgery.
3. American Board of Internal Medicine Certificate of
Added Qualifications in Interventional Cardiology.
4. Board Certification in Thoracic Surgery by the Ameri-
can Board of Thoracic Surgery.
5. American Board of Internal Medicine Board Certifi-
cation with additional certification in endovascular
medicine through the American Board of Vascular
Medicine.
To ensure the safe and effective application of TEVAR,
the following four knowledge and skill-set requirements
must be vested individually or collectively in the physician
or physicians performing every TEVAR procedure.
1. Familiarity with selecting patients; interpreting
CT scans and 3-dimensional reconstructions; measur-
ing; planning; and performing endovascular aneurysm
repair, as evidenced by successful performance as the pri-
mary operator of 25 abdominal endografts in the previous 2
years or of 10 thoracic endografts in the previous 2 years.
The procedure most technically similar to TEVAR is
EVAR, which is routinely performed by vascular surgeons,
interventional radiologists, interventional cardiologists, or
interventional vascular medicine physicians, acting inde-
pendently or collaboratively. Skills with CT interpretation
and measurement of vascular dimensions, proper sizing and
selection of endoprostheses, techniques for delivering
large-diameter devices through large (18F to 24F) sheaths,
and endograft delivery systems and deployment mecha-
nisms are common to both procedures. Correct device
sizing and selection are required to avoid type I endoleaks,
migration, and device failure. Reducing the risk of iliac
artery injury (rupture or dissection) and rapid recognition
and treatment of these injuries are critical for optimal
patient outcomes. Familiarity with the long-term follow-up
of endografts, reassessment for morphologic changes and
device failure, and late complication management is neces-
sary to match the outcomes of the pivotal clinical trials.
These skills are developed with significant experience with
abdominal and thoracic aorta endovascular repair, hence
this requirement.
2. Peripheral intervention skills to perform aortog-
raphy, bail out covered side-branch vessels, and treat
access artery injuries, as evidenced by competency in
catheter-based peripheral intervention, as defined by suc-
cessful performance of the specified number of endovascu-
lar procedures in either of the two commonly adopted
endovascular credentialing standards:
A. The ACC/ACP/SCAI/SVMB/SVS clinical compe-
tence statement on vascular medicine and catheter-
based peripheral vascular interventions.11B. The American Heart Association training standards for
physicians performing peripheral angioplasty and other
percutaneous peripheral vascular interventions.12
TEVAR is first and foremost an endovascular proce-
dure, and comprehensive endovascular skills are necessary
for its safe and effective performance. Fundamental to
TEVAR are technical and interpretative skills of thoracic
and visceral aortic angiography, as well as of selective bra-
chiocephalic and mesenteric angiography. Adjustment of
gantry angles, optimization of injection rates and image-
acquisition parameters, and application of postprocessing
functions are essential skills that optimize precise deploy-
ment near critical side branches. Furthermore, in the case of
device maldeployment with critical side-branch vessel com-
promise or device collapse, knowledge of the wide array of
endoluminal instrumentation and facility with advanced
endovascular techniques can effect an endoluminal resolu-
tion to what might otherwise require surgical intervention
and, possibly, result in severe or fatal complications. Even
routine TEVAR cases can require advanced endovascular
diagnostic and interventional skills, such as intravascular
ultrasonography, intravascular snaring, coil embolization,
and side-branch angioplasty and stenting. Although most
recent graduates of vascular surgery, interventional radiol-
ogy, interventional cardiology, and vascular medicine fel-
lowships can be expected to have had sufficient peripheral
endovascular training to be qualified as peripheral interven-
tionists, the same cannot be said for earlier certificate hold-
ers. Consequently, physicians from all specialties applying
for TEVAR credentials will be expected to document their
cases and outcomes to qualify under the guidelines of one of
the aforementioned multispecialty consensus documents.
3. Knowledge of thoracic aortic pathology; its di-
agnosis, natural history, and management options; and
recognition and treatment of common complications,
such as spinal cord ischemia, renal failure, stroke, myocar-
dial ischemia, and atheroembolization, as evidenced by one
of the following:
A. Board Certification in Vascular Surgery by the American
Board of Surgery.
B. Board Certification in Thoracic Surgery by the American
Board of Thoracic Surgery.
C. Attendance at a minimum of 20 hours of CME specifi-
cally devoted to endovascular repair of thoracic aortic
pathology in the previous 2 years.
Regardless of surgical board certification, all physicians
participating in the team should have completed a mini-
mum of 10 hours of CME specifically devoted to endovas-
cular repair of thoracic aortic pathology within the previous
2 years. A comprehensive understanding of the indications
for intervention on the various thoracic aortic pathologic
processes that can be treated by TEVAR is required to
ensure appropriate application of this new therapy. Al-
though the morbidity associated with TEVAR can be sig-
nificant, it is typically less frequent and severe than with the
open surgical alternatives. Nonetheless, it is important to
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cations commonly encountered in thoracic interventions,
such as stroke, paraplegia, microembolization, and renal
failure. Furthermore and ideally, clinicians committed to
the diagnosis and treatment of thoracic aortic pathology
can be expected to develop specific programs that optimize
the clinical care of these patients. In the initial stages of
program development, formal CME for all team members
demonstrates this commitment and would be expected to
be repeated every 2 years. A minimum volume of 10 TEVAR
procedures over 2 years would be considered to be the mini-
mum necessary to maintain an active TEVAR program.
4. Capability to obtain and repair access to the
vascular system at the brachial, common femoral, or
common iliac artery levels and to perform brachioce-
phalic transposition or extra-anatomic revasculariza-
tions, as evidenced by one of the following:
A. Board Certification in Vascular Surgery by the American
Board of Surgery.
B. Board Certification in Thoracic Surgery by the American
Board of Thoracic Surgery.
Although 75% to 85% of patients will have external iliac
arteries of adequate size that are sufficiently free of prob-
lematic tortuosity or calcification to allow TEVAR from a
common femoral site of access, even these will require its
surgical exposure, at least for the foreseeable future. Fur-
thermore, in all larger series of TEVAR, aortoiliac exposure
and conduit construction have been required with signifi-
cant frequency: 15% in the first pivotal trial of an approved
device in the United States.10 In this same investigational
trial, 20% of TEVAR procedures involved planned covering
of the left subclavian artery, all of which underwent man-
dated brachiocephalic revascularization. Although not all
of these would require revascularization in standard clinical
practice, the need for brachiocephalic revascularization will
be present in a sizable number of patients. Considering the
issues associated with obtaining, maintaining, and repairing
vascular access vessels, as well as the not-infrequent need for
brachiocephalic revascularization, the participation of a
qualified vascular or cardiovascular surgeon in all TEVAR
procedures is imperative.
Although fear of the need for an acute surgical conver-
sion prompted many to perform their early TEVAR proce-
dures in the operating room under portable fluoroscopic
imaging, this has proven to be an extremely rare occur-
rence, thus opening the door to the advanced imaging
options available in dedicated angiographic facilities, such
as rotational angiography and intraprocedural CT imaging.
Testimony to the safety of this procedure comes from the
Gore TAG trial,10 the basis for the first Food and Drug
Administration approval of a thoracic aortic endograft,
which reported no acute surgical conversions or intrapro-
cedural ruptures in any of the 142 patients enrolled. Pre-
liminary (unpublished) data from the VALOR trial of a
Medtronic thoracic aortic endograft are similarly encourag-
ing, revealing only 1 acute surgical conversion out of 150
TEVAR procedures (a rate of 0.7%) in their high-risk arm.Therefore, although any alternative facilities should still
have to meet surgical standards of sterility and have tables
and lighting suitable for the commonly required access and
revascularization procedures, just as for coronary angio-
plasty, they need not be ideal for performance of a thora-
cotomy and open thoracic aortic repair in view of the rarity
of the need for this. Similarly, again as for coronary, carotid,
or renal angioplasty, there is no justifiable requirement for
a surgical suite or operating team to be held on standby
during performance of routine TEVAR procedures. This
demonstrated safety of TEVAR is testimony not only to the
engineering that has gone into these devices to enhance
their deliverability and performance, but also to the out-
comes that can be expected when qualified interventionists
are performing the procedure.
MAINTENANCE OF CERTIFICATION
Because TEVAR is a relatively new procedure, the
requisite annual volume a physician needs to perform to
maintain clinical competence is unknown. Considering the
typical team approach, members of which may vary, and the
fact that the requisite surgical skills are part and parcel of a
standard vascular or cardiovascular surgery practice and the
requisite endovascular skills are fundamental to an active
endovascular interventional practice, maintenance of certi-
fication may be more appropriate for the TEVAR program
rather than for its individual physicians. Individual physi-
cians would be expected to maintain certification and priv-
ileges in their respective core disciplines and to participate
in 10 hours of CME specifically devoted to TEVAR every 2
years, the combination of which would be believed to be
sufficient for maintenance of their individual TEVAR priv-
ileges. For the program as a whole to be sufficiently active
to warrant continuation of TEVAR, it would be expected
to have successfully performed at least 10 TEVAR proce-
dures over the previous 2 years. Having an active EVAR
program could conceivably decrease the TEVAR require-
ments because of the similarity of the two procedures.
CONCLUSIONS
Endovascular repair of thoracic aortic pathology has
emerged as an alternative to open surgical repair that has
been associated with reduced morbidity and more rapid
recovery. This therapy was developed in most centers by
teams of physicians with the complementary skill sets nec-
essary to address the surgical and endovascular challenges
of the procedure. In a few centers, exceptional individual
physicians have acquired all of the necessary skills to provide
TEVAR independently, although this is not the usual situ-
ation. When the multidisciplinary approach is used, signif-
icant continued participation of every member of the team
is necessary to maintain the desired results of the program.
Undoubtedly, this technology will mature, and just as the
techniques and skills required to competently perform the
procedure will evolve, so should these standards. Hospitals
and physicians seeking to provide this new therapy should
assemble and support a program staffed by surgeons and
JOURNAL OF VASCULAR SURGERY
April 2006862 SVS/SIR/SCAI/SVMB Writing Committeeinterventionists who individually or collectively possess all
of the requisite clinical competencies.
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APPENDIX
Writing committee members of this clinical compe-
tence statement are Kim J. Hodgson, MD, Jon S. Mat-
sumura, MD, and Enrico Ascher, MD, for the Society for
Vascular Surgery; Michael D. Dake, MD, David Sacks,
MD, and Katharine Krol, MD, for the Society of Interven-
tional Radiology; and Robert M. Bersin, MD, for the
Society for Cardiovascular Angiography and Interventions.
When citing this document, the Society for Vascular
Surgery, the Society for Interventional Radiology, the So-
ciety for Cardiovascular Angiography and Interventions,
and the Society for Vascular Medicine and Biology would
appreciate the following citation format: Hodgson KJ,
Matsumura JS, Ascher E, Dake MD, Sacks D, Krol K,
Bersin R. SVS/SIR/SCAI/SVMB clinical competence
statement on thoracic endovascular aortic repair
(TEVAR)—multispecialty consensus recommendations, a
report of the SVS/SIR/SCAI/SVMB Writing Committee
to develop a clinical competence standard for TEVAR.
